Psychoneuroendocrinology 38 , 12591270 (2013)
3 These findings move GLP-1s out of the weight-loss drug category and into the category of proven cardiovascular risk-reduction tools
What approach do you recommend dermatologists take with patients who are either currently on or are considering using GLP-1 agonists
People already dealing with bloating from GLP-1 medications should approach this supplement with particular caution, as the effects can stack
Some people need a higher dose to prevent weight regain, while others are able to come down to a much lower dose
Months 4-6: Approaching Goals By mid-program, most Ponte Vedra Beach and Jacksonville patients have lost 10-15% of starting body weight, established healthier eating habits that feel sustainable, improved fitness and mobility, and normalized health markers (blood pressure, cholesterol, A1C)